Amantadine in the treatment of Parkinson's syndrome: studied in 31 patients for 3 months
Campanella, G.; Zallone, E.; Buscaino, G.A.
Acta Neurologica 27(5): 491-500
1972
ISSN/ISBN: 0001-6276 PMID: 4564842 Document Number: 55718
Document emailed within 1 workday
Related Documents
Gospavić, J.; Vidaković, Z. 1974: Effectiveness of a combination therapy in the Parkinson syndrome by amantadine hydrochloride and anticholinergic agents Srpski Arhiv Za Celokupno Lekarstvo 102(6): 447-457Pendefunda, G.; Pollingher, B.; Stefanache, F.; Gavril, A.; Oprisan, C.; Merling, M.; Nemteanu, E.; Ciunru, M.; Koropitzer, I. 1975: The treatment with L-dopa and amantadine in Parkinson's disease Therapia Hungarica 23(1): 12-16
Fasano, V.A.; Urciuoli, R.; Broggi, G. 1971: On the treatment of Parkinson's disease with intravenous administration of amantadine (77 cases) Minerva Medica 62(82): 3968-3970
Dzudza, M.; Dzudza, D. 1974: Comparative study on Parkopan, Amantadine and L-dopa in the treatment of Parkinson's disease Medicinski Arhiv 28(4): 407-415
Puca, F.M.; Bricolo, A.; Turella, G. 1972: Effects of L-dopa or amantadine treatment on the spindles of sleep in Parkinson's syndromes Revue Neurologique (Paris) 127(2): 313
Campbell, A.M.; Williams, M.J. 1972: Trial of amantadine in Parkinson's disease British Journal of Clinical Practice 26(1): 19-22
Hägglund, J.; Aquilonius, S.M.; Bergström, K.; Eckernäs, S.A.; Hartvig, P.; Lundqvist, H.; Långström, B.; Malmborg, P.; Någren, K. 1987: Regional kinetics of [11C]methylspiperone in the brain studied by positron emission tomography in patients with Parkinson's disease Advances in Neurology 45: 99-101
Griffiths, A.V.; Parker, W.N.; Palmer, R.M. 1971: Experiences with amantadine hydrochloride in Parkinson's disease Practitioner 207(241): 679-680
Danielczyk, W. 1995: Twenty-five years of amantadine therapy in Parkinson's disease Journal of Neural Transmission. Supplementum 46: 399-405
Blümlein, G. 1997: Successful use of amantadine in treatment of malignant neuroleptic syndrome Psychiatrische Praxis 24(5): 257-258
Kadykov, A.S. 1976: The effectiveness of amantadine (midantan) in the treatment of the parkinsonian syndrome Zhurnal Nevropatologii i Psikhiatrii Imeni S.S. Korsakova 76(2): 174-178
Horiguchi, J.; Inami, Y.; Miyoshi, N.; Kakimoto, Y. 1985: Restless legs syndrome in four parkinsonian patients treated with amantadine Rinsho Shinkeigaku 25(2): 153-156
Silver, D.E.; Sahs, A.L. 1971: Double blind study using amantadine hydrochloride in the therapy of Parkinson's disease Transactions of the American Neurological Association 96: 307-308
Foster, G.R. 1998: Amantadine in the treatment of patients with chronic hepatitis C Italian Journal of Gastroenterology and Hepatology 30(6): 614-615
Ferraris, M. 1971: Psychological status of patients with Parkinsonism during treatment with amantadine hydrochloride and L-Dopa Minerva Medica 62(82): 3971-3973
Fischer, P.A. 1983: Drug treatment of Parkinson syndrome Die Medizinische Welt 34(7): 220-221
Glabb, J.; Hübner, W.; Glabb, S. 1973: Treatment of Parkinson's syndrome using L-dopa. 2 Zeitschrift für Arztliche Fortbildung 67(15): 745-753
Sigwald, J.; Chomette, G.; Raymondeaud, C. 1972: Antagonism and competition between Parkinson's syndrome and the chorea and athetosis syndrome. Clinical cases of the association (including an anatomoclinical case). The abnormal movements provoked by levodopa in Parkinsonian patients La semaine des hopitaux: organe fonde par l'Association d'enseignement medical des hopitaux de Paris 48(9): 609-624
Fischer, P.A. 1987: Long-term course in Parkinson's syndrome and cerebral polypathy (Parkinson plus) Advances in Neurology 45: 235-238
Jovicić, A. 1985: Parkinson's syndrome. Etiopathogenesis and possibilities of treatment Vojnosanitetski Pregled 42(3): 206-210